245 related articles for article (PubMed ID: 2425060)
1. Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy.
Hoskin P; Dilly S; Easton D; Horwich A; Hendry W; Peckham MJ
J Clin Oncol; 1986 Jul; 4(7):1031-6. PubMed ID: 2425060
[TBL] [Abstract][Full Text] [Related]
2. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
3. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
4. Germ-cell tumors of the testis: improved results in a prospective study using combined modality therapy and biochemical tumor markers.
Scardino PT; Skinner DG
Surgery; 1979 Jul; 86(1):86-93. PubMed ID: 88077
[No Abstract] [Full Text] [Related]
5. Analysis of clinical-pathologic variables, staging and prognostic groups, and therapeutic results of 106 germ-cell testicular tumors.
Bonet AS; Muñoz-Delgado EG; Vico FJ; Ruiz JC; Chapado MS
Arch Esp Urol; 2011 Dec; 64(10):972-80. PubMed ID: 22228895
[TBL] [Abstract][Full Text] [Related]
6. Surveillance following orchiectomy for clinical stage I testicular germ-cell malignancy.
Peckham MJ
Prog Clin Biol Res; 1985; 203():523-38. PubMed ID: 2421341
[No Abstract] [Full Text] [Related]
7. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
[TBL] [Abstract][Full Text] [Related]
8. Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis.
Fedyanin M; Tryakin A; Bulanov A; Fainshtein I; Zakharova T; Matveev V; Garin A; Tjulandin S
Urol Oncol; 2014 Jan; 32(1):32.e27-33. PubMed ID: 23628310
[TBL] [Abstract][Full Text] [Related]
9. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
Schmidt P; Haas RJ; Göbel U; Calaminus G
Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
[TBL] [Abstract][Full Text] [Related]
10. Current management of stage I testicular non-seminomatous germ cell tumours.
Pectasides D; Pectasides E; Constantinidou A; Aravantinos G
Crit Rev Oncol Hematol; 2009 May; 70(2):114-23. PubMed ID: 18805019
[TBL] [Abstract][Full Text] [Related]
11. Surveillance alone versus radiotherapy after orchiectomy for clinical stage I nonseminomatous testicular cancer. Danish Testicular Cancer Study Group.
Rørth M; Jacobsen GK; von der Maase H; Madsen EL; Nielsen OS; Pedersen M; Schultz H
J Clin Oncol; 1991 Sep; 9(9):1543-8. PubMed ID: 1714948
[TBL] [Abstract][Full Text] [Related]
12. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and survival of testicular tumours in a Southeast Asian university hospital: a ten-year review.
Tan GH; Azrif M; Shamsul AS; Ho CC; Praveen S; Goh EH; Bahadzor B; Ismail F; Zulkifli MZ
Asian Pac J Cancer Prev; 2011; 12(10):2727-30. PubMed ID: 22320982
[TBL] [Abstract][Full Text] [Related]
14. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only.
Ondrus D; Ondrusova M; Hornak M; Matoska J
Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
16. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
[TBL] [Abstract][Full Text] [Related]
17. [Is risk-oriented therapy in stage I non-seminoma tumor advisable?].
Krege S; Rübben H
Urologe A; 1993 May; 32(3):171-5. PubMed ID: 8390119
[TBL] [Abstract][Full Text] [Related]
18. Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance.
Thompson PI; Nixon J; Harvey VJ
J Clin Oncol; 1988 Oct; 6(10):1597-603. PubMed ID: 2459319
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy for stage I non-seminomatous testicular cancer.
Abratt RP; Pontin AR; Barnes RD; Reddi BV
S Afr Med J; 1994 Sep; 84(9):605-7. PubMed ID: 7530863
[TBL] [Abstract][Full Text] [Related]
20. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]